Summary
Elevance Health, Inc. (formerly Anthem, Inc.) held its Annual Meeting of Shareholders on May 26, 2021, where key corporate governance matters were put to a vote. The primary outcomes included the overwhelming election of three directors to three-year terms, indicating strong shareholder confidence in the current board leadership. Additionally, shareholders provided an advisory approval of the company's executive compensation, reflecting general satisfaction with the remuneration policies for its top executives. The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2021 was also overwhelmingly ratified, signaling continued trust in the company's financial oversight and auditing processes. While these votes are largely routine, they provide valuable insight into shareholder sentiment regarding the company's governance and executive remuneration. The strong support for director re-elections and executive compensation advisory votes suggests a stable operating environment and alignment between management and shareholders on strategic direction and oversight. The ratification of the independent auditor further reinforces the commitment to transparency and accountability in financial reporting.
Key Highlights
- 1Three directors were elected to serve three-year terms expiring in 2024, with significant majority support from shareholders.
- 2Shareholders provided an advisory "Say-on-Pay" vote, approving the company's executive compensation with a substantial majority.
- 3The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2021 was ratified by an overwhelming majority of votes.
- 4The Annual Meeting of Shareholders took place on May 26, 2021.
- 5Lewis Hay, III, Antonio F. Neri, and Ramiro G. Peru were among the elected directors.
- 6Broker non-votes were recorded for all director elections, a common occurrence in such meetings.